EUVIMEDDescobrir EUVIMED
Open access · CC BY-NC-ND 4.0

Macrophages producing chondroitin sulfate proteoglycan‐4 induce neuro‐cardiac junction impairment in Duchenne muscular dystrophy

Marika Milan iD, Fabio Maiullari iD, Maila Chirivì, Maria Grazia Ceraolo, Rebecca Zigiotto, Andrea Soluri iD, Silvia Maiullari, Elisa Landoni, Dario Di Silvestre, Francesca Brambilla, Pierluigi Mauri, Veronica De Paolis iD and 14 more

The Journal of Pathology · 2025

DOI: 10.1002/path.6362 ↗

At a glance

Journal article in The Journal of Pathology, 2025. Written by Marika Milan and 25 co-authors. Institution: Neurology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. Major MEDLINE topics: Muscular Dystrophy, Duchenne, Macrophages, Mice, Inbred mdx. Cited 8 times so far (Crossref); 46 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Fondazione Regionale per la ricerca biomedica, Italian Ministry of Health, Italfarmaco.

ResumoSubjectsDados bibliográficosCiteRelated studies

Abstract (original language)

Duchenne muscular dystrophy (DMD) is caused by the absence of the full form of the dystrophin protein, which is essential for maintaining the structural integrity of muscle cells, including those in the heart and respiratory system. Despite progress in understanding the molecular mechanisms associated with DMD, myocardial insufficiency persists as the primary cause of mortality, and existing therapeutic strategies remain limited. This study investigates the hypothesis that a dysregulation of the biological communication between infiltrating macrophages (MPs) and neurocardiac junctions exists in dystrophic cardiac tissue. In a mouse model of DMD ( mdx ), this phenomenon is influenced by the over‐release of chondroitin sulfate proteoglycan‐4 (CSPG4), a key inhibitor of nerve sprouting and a modulator of the neural function, by MPs infiltrating the cardiac tissue and associated with dilated cardiomyopathy, a hallmark of DMD. Givinostat, the histone deacetylase inhibitor under current development as a clinical treatment for DMD, is effective at both restoring a physiological microenvironment at the neuro‐cardiac junction and cardiac function in mdx mice in addition to a reduction in cardiac fibrosis, MP‐mediated inflammation, and tissue CSPG4 content. This study provides novel insight into the pathophysiology of DMD in the heart, identifying potential new biological targets. © 2024 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Subjects

MeSH terms (MEDLINE)

Muscular Dystrophy, DuchenneMacrophagesMice, Inbred mdxAnimalsChondroitin Sulfate ProteoglycansMiceDisease Models, AnimalNeuromuscular JunctionMaleMyocardiumMice, Inbred C57BLFibrosis

Author keywords

DMD heart failurecardiac fibrosiscardiac innervationdilated cardiomyopathyextracellular matrixinflammationmacrophagesproteoglycans

Substances

Chondroitin Sulfate Proteoglycans

Authors and institutions

  • Neurology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Fondazione Istituto Nazionale di Genetica Molecolare (INGM) 'Romeo ed Enrica Invernizzi', Milan, Italy.
  • PhD Program in Cellular and Molecular Biology, Department of Biology, University of Rome 'Tor Vergata', Rome, Italy.
  • Department of Molecular Medicine, Sapienza University, Rome, Italy.
  • Unit of Molecular Neurosciences, University Campus Bio-Medico, Rome, Rome, Italy.
  • Institute of Biochemistry and Cell Biology, National Research Council, Rome, Italy.

ORCID profiles: Marika Milan, Fabio Maiullari, Andrea Soluri, Veronica De Paolis, Nicole Fratini, Chiara Parisi, Claudia Bearzi, Roberto Rizzi

Funding

  • Fondazione Regionale per la ricerca biomedica
  • Italian Ministry of Health
  • Italfarmaco
  • European Union
  • Ministero della Salute
  • European Commission

Cite

APA

Milan, M., Maiullari, F., Chirivì, M., Ceraolo, M. G., Zigiotto, R., Soluri, A., Maiullari, S., Landoni, E., Silvestre, D. D., Brambilla, F., Mauri, P., De Paolis, V., Fratini, N., Crosti, M. C., Cordiglieri, C., Parisi, C., Calogero, A., Seliktar, D., Torrente, Y., …, & Rizzi, R. (2025). Macrophages producing chondroitin sulfate proteoglycan‐4 induce neuro‐cardiac junction impairment in Duchenne muscular dystrophy. The Journal of Pathology. https://doi.org/10.1002/path.6362

Vancouver

Milan M, Maiullari F, Chirivì M, Ceraolo MG, Zigiotto R, Soluri A, et al. Macrophages producing chondroitin sulfate proteoglycan‐4 induce neuro‐cardiac junction impairment in Duchenne muscular dystrophy. The Journal of Pathology. 2025. doi:10.1002/path.6362

BibTeX
@article{Milan2025,
  author = {Milan, Marika and Maiullari, Fabio and Chirivì, Maila and Ceraolo, Maria Grazia and Zigiotto, Rebecca and Soluri, Andrea and Maiullari, Silvia and Landoni, Elisa and Silvestre, Dario Di and Brambilla, Francesca and Mauri, Pierluigi and De Paolis, Veronica and Fratini, Nicole and Crosti, Maria Cristina and Cordiglieri, Chiara and Parisi, Chiara and Calogero, Antonella and Seliktar, Dror and Torrente, Yvan and Lanzuolo, Chiara and Dotti, Gianpietro and Toccafondi, Mirco and Bombaci, Mauro and De Falco, Elena and Bearzi, Claudia and Rizzi, Roberto},
  title = {Macrophages producing chondroitin sulfate proteoglycan‐4 induce neuro‐cardiac junction impairment in Duchenne muscular dystrophy},
  journal = {The Journal of Pathology},
  year = {2025},
  doi = {10.1002/path.6362}
}
Start for free →